I
Isaac Dreyfus
Researcher at NewYork–Presbyterian Hospital
Publications - 7
Citations - 2455
Isaac Dreyfus is an academic researcher from NewYork–Presbyterian Hospital. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 3, co-authored 4 publications receiving 1724 citations.
Papers
More filters
Journal ArticleDOI
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up
Behnood Bikdeli,Mahesh V. Madhavan,David Jiménez,Taylor Chuich,Isaac Dreyfus,Elissa Driggin,Caroline Der Nigoghossian,Walter Ageno,Mohammad Madjid,Yutao Guo,Liang V. Tang,Yu Hu,Jay Giri,Mary Cushman,Isabelle Quéré,Evangelos Dimakakos,C. Michael Gibson,C. Michael Gibson,Giuseppe Lippi,Emmanuel J. Favaloro,Jawed Fareed,Joseph A. Caprini,Alfonso Tafur,John R. Burton,Dominic P. Francese,Elizabeth Y. Wang,Anna Falanga,Claire McLintock,Beverley J. Hunt,Alex C. Spyropoulos,Geoffrey D. Barnes,John W. Eikelboom,John W. Eikelboom,Ido Weinberg,Sam Schulman,Marc Carrier,Gregory Piazza,Gregory Piazza,Joshua A. Beckman,P. Gabriel Steg,Gregg W. Stone,Stephan Rosenkranz,Samuel Z. Goldhaber,Samuel Z. Goldhaber,Sahil A. Parikh,Manuel Monreal,Harlan M. Krumholz,Stavros Konstantinides,Jeffrey I. Weitz,Gregory Y.H. Lip,Gregory Y.H. Lip +50 more
TL;DR: The current understanding of the pathogenesis, epidemiology, management and outcomes of patients with COVID-19 who develop venous or arterial thrombosis, and of those with preexistingThrombotic disease who develop CO VID-19 are reviewed.
Journal ArticleDOI
Pharmacological Agents Targeting Thromboinflammation in COVID-19: Review and Implications for Future Research.
Behnood Bikdeli,Behnood Bikdeli,Mahesh V. Madhavan,Aakriti Gupta,Aakriti Gupta,David Jiménez,John R. Burton,Caroline Der Nigoghossian,Taylor Chuich,Shayan Nabavi Nouri,Isaac Dreyfus,Elissa Driggin,Sanjum S. Sethi,Kartik Sehgal,Kartik Sehgal,Saurav Chatterjee,Walter Ageno,Mohammad Madjid,Yutao Guo,Yutao Guo,Liang V. Tang,Yu Hu,Laurent Bertoletti,Jay Giri,Jay Giri,Jay Giri,Mary Cushman,Isabelle Quéré,Evangelos Dimakakos,C. Michael Gibson,C. Michael Gibson,Giuseppe Lippi,Emmanuel J. Favaloro,Jawed Fareed,Alfonso Tafur,Alfonso Tafur,Dominic P. Francese,Jaya Batra,Anna Falanga,Kevin J. Clerkin,Nir Uriel,Ajay J. Kirtane,Claire McLintock,Beverley J. Hunt,Alex C. Spyropoulos,Geoffrey D. Barnes,John W. Eikelboom,Ido Weinberg,Sam Schulman,Sam Schulman,Marc Carrier,Gregory Piazza,Gregory Piazza,Joshua A. Beckman,Martin B. Leon,Gregg W. Stone,Stephan Rosenkranz,Samuel Z. Goldhaber,Samuel Z. Goldhaber,Sahil A. Parikh,Manuel Monreal,Harlan M. Krumholz,Stavros Konstantinides,Jeffrey I. Weitz,Gregory Y.H. Lip,Gregory Y.H. Lip +65 more
TL;DR: Novel dosing approaches are described for commonly used antithrombotic agents (especially heparin-based regimens) and the potential use of less widely used antithsombotic drugs in the absence of confirmed thrombosis.
Journal ArticleDOI
Investigating Lipid-Modulating Agents for Prevention or Treatment of COVID-19: JACC State-of-the-Art Review.
Azita Hajhossein Talasaz,Parham Sadeghipour,Maryam Aghakouchakzadeh,Isaac Dreyfus,Hessam Kakavand,Hamid Ariannejad,Aakriti Gupta,Mahesh V. Madhavan,Benjamin W. Van Tassell,David Jiménez,Manuel Monreal,Muthiah Vaduganathan,John Fanikos,Dave L. Dixon,Gregory Piazza,Sahil A. Parikh,Deepak L. Bhatt,Gregory Y.H. Lip,Gregg W. Stone,Harlan M. Krumholz,Peter Libby,Samuel Z. Goldhaber,Behnood Bikdeli +22 more
TL;DR: In this paper, the authors summarized the ongoing or completed RCTs of lipid-modulating agents in COVID-19 and the implications of these trials for patient management, including 17 statin trials, 14 omega-3 fatty acids trials, 3 fibrate trials, 5 niacin trials and 1 dalcetrapib trial.
Posted ContentDOI
Lipid-Modulating Agents for Prevention or Treatment of COVID-19 in Randomized Trials
Azita Hajhossein Talasaz,Azita Hajhossein Talasaz,Parham Sadeghipour,Maryam Aghakouchakzadeh,Isaac Dreyfus,Hessam Kakavand,Hamid Ariannejad,Amolika Gupta,Amolika Gupta,Mahesh V. Madhavan,Van Tassell Bw,David Jiménez,Manuel Monreal,Muthiah Vaduganathan,John Fanikos,Dave L. Dixon,Gregory Piazza,Sahil A. Parikh,Deepak L. Bhatt,Gregory Y.H. Lip,Gregory Y.H. Lip,Gregg W. Stone,Harlan M. Krumholz,Peter Libby,Samuel Z. Goldhaber,Behnood Bikdeli,Behnood Bikdeli,Behnood Bikdeli +27 more
TL;DR: In this paper, the authors summarized the ongoing or completed randomized controlled trials (RCTs) of lipid modulating agents in COVID-19 and the implications of these trials for patient management.
Journal ArticleDOI
Therapy for Renal Artery Stenosis: A Call for Change.
TL;DR: In this article , the authors present a brief case description of a patient who benefited from stenting in ARAS and provide a comprehensive review of ARAS; its prevalence, pathophysiology, clinical manifestations, diagnosis and treatment.